(Reuters) - British medical products maker Smith+Nephew (L:SN) said on Wednesday sales in April nearly halved as more patients postponed elective surgeries, such as hip replacements, due to coronavirus-driven lockdowns.
The company said revenue in the three months ended March 28 fell 7.6% to $1.13 billion on an underlying basis and April sales slumped 47%. (https://reut.rs/3frFu7e)
Analysts on average were expecting first-quarter sales of $1.12 billion, down 8.1% on an underlying basis, according to a company-compiled consensus http://www.smith-nephew.com/investor-centre/reporting/analyst-consensus of 8 analysts.